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Abstract
This investigation examines the influence of alpha-toxin (Hla) during USA300 infection of human leukocytes. Survival of an
USA300 isogenic deletion mutant of hla (USA300Dhla) in human blood was comparable to the parental wild-type strain and
polymorphonuclear leukocyte (PMN) plasma membrane permeability caused by USA300 did not require Hla. Flow
cytometry analysis of peripheral blood mononuclear cells (PBMCs) following infection by USA300, USA300Dhla, and
USA300Dhla transformed with a plasmid over-expressing Hla (USA300Dhla Comp) demonstrated this toxin plays
a significant role inducing plasma membrane permeability of CD14
+, CD3
+, and CD19
+ PBMCs. Rapid plasma membrane
permeability independent of Hla was observed for PMNs, CD14
+ and CD19
+ PBMCs following intoxication with USA300
supernatant while the majority of CD3
+ PBMC plasma membrane permeability induced by USA300 required Hla. Addition of
recombinant Hla to USA300Dhla supernatant rescued CD3
+ and CD19
+ PBMC plasma membrane permeability generated by
USA300 supernatant. An observed delay in plasma membrane permeability caused by Hla in conjunction with Annexin V
binding and ApoBrdU Tunel assays examining PBMCs intoxicated with recombinant Hla or infected with USA300,
USA300Dhla, USA300Dhla Comp, and USA300DsaeR/S suggest Hla induces programmed cell death of monocytes, B cells,
and T cells that results in plasma membrane permeability. Together these findings underscore the importance of Hla during
S. aureus infection of human tissue and specifically demonstrate Hla activity during USA300 infection triggers programmed
cell death of human monocytes, T cells and B cells that leads to plasma membrane permeability.
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Introduction
Staphylococcus aureus is a common Gram-positive bacterial
pathogen that can produce a wide spectrum of disease in humans,
ranging from superficial skin abscesses to invasive life-threatening
disease. Emerging antibiotic resistant and hypervirulent strains of
S. aureus continuously compromise our ability to treat these
infections, emphasized by a 2005 survey indicating over 18,000
deaths can be attributed to invasive methicillin resistant S. aureus
(MRSA) infection in the United States alone [1]. In particular,
strains of community-associated MRSA (CA-MRSA) distinct from
previously characterized hospital-associated MRSA (HA-MRSA)
are a prominent cause of skin and soft-tissue infections and are
noted for their enhanced capacity to produce disease in humans
[2,3]. The mechanisms behind the increased virulence observed
for CA-MRSA strains remain incompletely defined.
Currently the CA-MRSA strain identified by pulse-field gel
electrophoresis (PFGE) as type USA300 is a leading cause of soft-
tissue infections in the United States [2,4]. This strain exhibits
a heightened ability to elicit human polymorphonuclear leukocyte
(PMN) destruction in vitro as well as produce more severe
dermonecrotic soft-tissue infections in mice relative to other S.
aureus strains [5,6,7]. Evidence suggests differential expression of
core genome-encoded virulence elements is largely responsible for
the enhanced virulence observed for USA300 [8,9,10]. Indeed,
elevated expression of virulence gene regulators agr, saeR/S, and
sarA as well as the pore-forming toxin hla in USA300 relative to
USA400 is thought to contribute to the increased pathogenicity of
this strain during rat models of pneumonia [11].
Hla is expressed at higher levels by USA300 during infection of
human tissue relative to in vitro growth [12] and is largely regulated
by the Agr and SaeR/S two-component systems [13,14,15,16].
Recent studies have demonstrated a robust direct regulation of hla
transcription by SaeR/S and strong attenuation of a USA300
isogenic deletion mutant of this two-component system, suggesting
Hla is a primary effector of SaeR/S and a critical component of
USA300 virulence [17,18]. Other research has shown the
expression of hla directly correlates with S. aureus virulence
[8,11,19] and immunization strategies targeting Hla provide
effective protection during murine models of S. aureus pneumonia
and soft-tissue infection caused by USA300 [5,20]. However, the
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not entirely clear.
To obtain a better understanding of how Hla furthers USA300
pathogenesis, this study examined the influence of this toxin
during infection of human blood, purified PMNs, and peripheral
blood mononuclear cells (PBMCs) by examining host cell plasma
membrane permeability, induction of programmed cell death, and
bacterial survival. This investigation demonstrates Hla generated
by USA300 triggers programmed cell death in human monocytes,
B cells, and T cells that results in plasma membrane permeability
while other USA300 components cause immediate plasma
membrane permeability to PMNs, monocytes, and B cells but
only minimally to T cells. Collectively these findings elucidate the
impact of this prominent S. aureus toxin on different human blood
cell types during infection by USA300.
Materials and Methods
Ethics Statement
All human studies were in accordance with an approved
protocol by the Montana State University Institutional Review
Board. Donors provided written consent to participate in the
study. This study (JVK041306) was approved on March 15, 2011.
Bacterial Strains and Culture
S. aureus strains were cultured and harvested as described
elsewhere [6,7,17,21]. S. aureus pulse-field gel electrophoresis type
USA300 (strain LAC) [22] was used to generate USA300Dhla as
described previously using oligonucleotides hla-Sal1_u-
pstream_fwd (59-TTCAATGTCGACGGTTAGTCAAAG -39),
hla-HindIII_upstream_rvs (59-TCGAAATTTTAAAGCTT-
GATTCAGACTC-39), hla-SacI_downstream_fwd (59-TAATG-
GAGCTCTAATTAATCCGAAATTAATCATG-39), and hla-
BamHI_downstream_rvs (59-TGTTCAAAACTTTTGGATCC-
CATTATGTG-39) and SalI, HindIII, SacI, and BamHI re-
striction digest [7,21,23]. USA300DsaeR/S was generated in
previous studies [17]. To construct the USA300Dhla complement-
ing clone, the hla gene was PCR amplified from USA300 genomic
DNA using oligonucleotides CLM445 (59-
GTTGTTGGATCCCCTTTCTTGAATTAACAATATAC-39)
and CLM446 (59-GTTGTTGAATTCGCCGAAAAACAT-
CATTTCTG), and cloned into pAH5 using BamHI and EcoRI
[24], then transformed into USA300Dhla to generate USA300Dhla
Comp. Construction of the USA300Dhla Comp plasmid was
confirmed by sequencing using primers CLM445, CLM446, and
CLM576 (59-CCTGTCGCTAATGCCGCAGATTCTG-39).
DNA sequencing was performed at the University of Iowa DNA
core facility.
For assays using S. aureus supernatants, 20 mL of TSB
supplemented with 5% glucose was inoculated with 200 mL
USA300 overnight culture, grown for 5 hours with shaking (37uC
and 255 rpm), centrifuged (5,0006g, 5 minutes, 4uC), and filtered
(0.2 mM). For infection assays, 1 mL of S. aureus grown to ME was
harvested by centrifugation (5,0006g, 5 minutes, 4uC), washed
twice with 1 mL DPBS, and resuspended in 1 mL DPBS (2610
8
CFU/mL) prior to inoculation.
PCR and Western Blot Analysis
PCR was performed using primers for ACME (ACME_fwd
GAGCCAGAAGTACGCGAG, ACME-
rvs CACGTAACTTGCTAGAACGAG) and hla (hla_fwd AAT-
GAATCCTGTCGCTAATGCCGC, hla_rvs TAAAGGCT-
GAAGGCCAGGCTAAAC). Western blot analyses for Hla were
performed as described [25] on filtered supernatants from S. aureus
cultures at 5 hours of growth using a rabbit polyclonal anti-Hla
antibody (Sigma). Known concentrations of serial diluted
recombinant Hla (Toxin Technology) were run on western blot
and subject to densitometry analysis to generate a standard curve
used to determine concentration of Hla (ng/mL) in 5 hour filtered
supernatant of indicated S. aureus cultures.
S. aureus Survival in Human Blood
Heparinized venous blood samples from healthy donors were
collected in accordance with a protocol approved by the
Institutional Review Board for Human Subjects at Montana State
University. All donors provided written consent to participate in
the study. S. aureus was harvested at the mid-exponential (ME)
phase of growth (2610
8 CFU/mL). Blood (3 mL) was inoculated
with 3610
5 CFU of S. aureus in a 5 mL culture tube and incubated
at 37uC with end-over-end rotation (20 rpm). Samples were
diluted in sterile deionized water to lyse blood cells and CFUs were
determined by plating on tryptic soy agar.
THP-1 Monocyte Cell Culture and Cytotoxicity Assay
THP1-XBlue-CD14 cells (InvivoGen, San Diego, CA) were
maintained around 1610
6 cells/mL in growth media (RPMI 1640
medium supplemented with 10% (v/v) endotoxin-free FBS,
200 mg/ml Zeocin and 250 mg/mL G418). THP1 cells (2–
4610
5 cells) in 100 mL assay medium were combined with
10 mL 5 hour filtered USA300 supernatant or TSB in wells of a flat
bottom 96 well plate, then incubated at 37uC for 24 hours. To
determine THP1 cell cytotoxicity, 50 mL of sample was analyzed
using a Homogeneous Membrane Integrity Assay (Promega)
following manufactures protocol. Experiments were performed 3
times with triplicate analysis conducted on each sample per
experiment.
Flow Cytometry
PBMCs and PMNs were isolated from freshly drawn human
blood under endotoxin free conditions (,25.0 pg/mL) as de-
scribed elsewhere [6]. Cell viability and purity of preparations
were assessed by flow cytometry (FACSCalibur; BD Biosciences).
For flow cytometry analysis, 20 mL of 5 hour S. aureus supernatants
undiluted or diluted with TSB were added to 1610
6 PBMCs or
PMNs in 100 mL RPMI with 5 mM HEPES. At indicated times
samples were stained with propidium iodide (Invitrogen, Molec-
ular Probes) and FITC or APC mouse anti-human CD3, APC
mouse anti-human CD4, APC mouse anti-human CD8, FITC or
APC mouse anti-human CD14, or APC mouse anti-human CD19
following the manufacturer’s protocol (BD Pharmingen). 0.1%
Triton-X 100 was used as a positive control for cell plasma
membrane permeability. Cells were analyzed with a FACSCalibur
Flow cytometer (BD Biosciences). The following formula was used
to determine % propidium iodide
+: %Propidium Iodide
+=(Mean
PI signal Experimental – Mean PI signal Blank)/(Mean PI signalTriton-X
– Mean PI signal Blank). For infection assays, PMNs or PBMCs
(1610
6) in 100 mL RPMI with 5 mM HEPES were combined
with 50 mL of undiluted or dilute S. aureus to obtain the indicated
multiplicity of infection (MOI). Samples were centrifuged (5006g,
5 minutes, 4uC), incubated at 37uC for indicated times, and
analyzed using flow cytometry as described above. Annexin V-
FITC binding assays (Trevigen, Inc) and ApoBrdU Tunel assays
(BD Pharmingen) were performed following the manufactures
protocol. For assays using recombinant Hla (rHla, Toxin
Technology, Inc), 10 mL of rHla or PBS was combined with
20 mL of undiluted supernatant, supernatant diluted with TSB, or
TSB alone and 1610
6 PBMCs or PMNs in 100 mL RPMI with
5 mM HEPES. The amount of rHla used in these assays is given
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generate 50% hemolysis of rabbit blood cells following one hour of
intoxication. Samples were incubated at 37uC for 60 minutes then
analyzed using flow cytometry as described above.
Statistical Procedures
Statistical significance was determined with Graphpad Prism
(version 4 Graphpad software) using student’s t-test or repeated-
measures analysis of variance with Tukey’s post-test for multiple
comparisons.
Results
Generating an Isogenic Deletion Mutant of hla in USA300
To examine the role of hla during S. aureus pathogenesis, we first
developed an isogenic deletion mutant of this toxin in USA300
strain LAC (USA300Dhla) using temperature sensitive allelic
replacement (Figure 1A) as previously described [7,21,23]. PCR
determined the presence of hla in USA300, USA300Dhla
harboring a plasmid expressing hla (USA300Dhla Comp), and an
isogenic deletion mutant of saeR/S in USA300 (USA300DsaeR/S)
but not in USA300Dhla (Figure 1B). Western blot confirmed the
deletion of hla in USA300Dhla and rescue of production in
USA300Dhla Comp (Figure 1C). Hla concentrations where
quantified in filtered supernatant from 5 hour cultures of
USA300, USA300Dhla, USA300Dhla Comp and in USA300D-
saeR/S using densitometry analysis (Figure 1C). Supernatant from
USA300 cultures contained 5.63461.398 ng/mL of Hla in
contrast to undetectable concentrations of Hla in supernatant
collected from USA300Dhla cultures. Relative to USA300,
USA300Dhla Comp supernatant contained a significantly higher
concentration of Hla (21.6266.494 ng/mL) while USA300DsaeR/
S contained a significantly lower concentration of Hla
(0.718360.6513 ng/mL). The diminished concentration of Hla
in USA300DsaeR/S supernatant supports saeR/S-mediated expres-
sion of Hla during in vitro growth as suggested by previous studies
[17,26].
Hla does not Play a Significant Role Inducing PMN Plasma
Membrane Permeability
We examined the ability of USA300 and USA300Dhla to induce
plasma membrane permeability of human PMNs (Figure 2).
Although rapid plasma membrane permeability was observed for
PMNs following intoxication with USA300 supernatants, no
significant differences in cytotoxicity could be detected between
USA300 and USA300Dhla supernatant (Figure 2A, 2B, and 2C).
Assays using USA300, USA300Dhla, USA300DsaeR/S, and
USA300Dhla Comp at different MOIs did not reveal any
differences in the ability of USA300, USA300Dhla, and
USA300Dhla Comp to induce PMN plasma membrane perme-
ability during infection while USA300DsaeR/S caused significantly
less PMN plasma membrane permeability at an MOI of 10
(Figure 2D). Under the conditions tested, these data indicate that
Hla is not required for PMN lysis by USA300 as previously
suggested [16] but are consistent with other investigations
demonstrating USA300 produces factors transcriptionally regulat-
ed by SaeR/S other than Hla that generate significant PMN and
monocyte plasma membrane permeability [17,25,27,28,29,30,31].
In support of these results, no significant difference in survival was
noted between USA300 and USA300Dhla during infection of
whole human blood while survival of USA300DsaeR/S was
significantly increased at 1 hour post-infection and significantly
decreased at 5 hours post-infection (Figure 2E). These findings
correspond to recent work demonstrating survival of a saeR/S
isogenic deletion mutant in PFGE type USA400 was significantly
reduced relative to the parental wild-type during infection of
human blood and upon exposure to PMNs [21]. The inability of
USA300DsaeR/S to recognize and appropriately respond to
human blood and/or PMN phagocytosis most likely accounts
for the differences in bacterial survival observed for USA300D-
saeR/S relative to USA300.
Influence of Hla on Plasma Membrane Permeability
Following Intoxication with with USA300, and
USA300Dhla Supernatant
Though Hla did not significantly influence PMN plasma
membrane permeability caused by USA300 (Figure 2), other
investigations indicate Hla produces pores on a variety of cell types
including human lymphocytes [32,33,34,35]. To examine the
cytotoxic capacity of Hla expressed by USA300 against different
Figure 1. Generation of an isogenic hla deletion mutant in
USA300. A) Construction of USA300Dhla using allelic gene replace-
ment. B) Colony PCR targeting hla and ACME and C) Western blot of Hla
in 5 hour USA300 supernatants from USA300, USA300Dhla (Dhla), Dhla
supplemented with a complement plasmid encoding hla (Dhla Comp),
and USA300DsaeR/S (DsaeR/S). Densitometry analysis of Western blots
was used to determine Hla concentration (ng/mL) of 5 hour filtered S.
aureus supernatant using a standardized curve of known rHla
concentrations. Data represents 4 replicate experiments. *P,0.05 and
**P,0.01 relative to USA300 as determined by paired one-tailed t-test.
doi:10.1371/journal.pone.0036532.g001
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+, CD14
+, and CD19
+ PBMCs were
examined for plasma membrane permeability at different time
points following exposure to USA300 or USA300Dhla supernatant
(Figure 3). As with PMNs, rapid plasma membrane permeability
was observed for CD14
+ PBMCs following exposure to USA300
supernatant and accounted for the majority of plasma membrane
permeability to these cell types (Figure 3A, 3B, and 3D).
Surprisingly, USA300Dhla supernatant caused significantly more
CD14
+ PBMC plasma membrane permeability at 15 minutes than
USA300 supernatant, indicating deletion of hla enhanced mono-
cyte plasma membrane permeability. In contrast, nearly all CD3
+
PBMC plasma membrane permeability was caused by Hla and
only became apparent after 60 minutes intoxication with USA300
supernatant (Figure 3A, 3B, and 3C). CD19
+ PBMCs exhibited
both rapid plasma membrane permeability that did not require
Hla as well as Hla-dependent plasma membrane permeability
following 60 minutes of intoxication (Figure 3A, 3B, and 3E).
USA300Dhla supernatant caused significantly more CD19
+
plasma membrane permeability than USA300 supernatant at 30
minutes, again suggesting that mechanisms contributing to plasma
membrane permeability that do not require Hla are enhanced in
USA300Dhla. Significant differences in CD19
+ PBMC plasma
membrane permeability caused by Hla could only be resolved
after 60 minutes of intoxication with USA300 supernatant, similar
to the influence of Hla on CD3
+ PBMCs. Collectively these results
indicate that primary human PMNs, monocytes, and B cells but
not T cells are susceptible to plasma membrane damage caused by
factors other than Hla within 15 minutes exposure to USA300
supernatants while T cell and B cell plasma membrane
permeability due to Hla only becomes evident after 60 minutes
intoxication.
Hla is a Major Cause of T Cell Plasma Membrane
Permeability during USA300 Infection
Previous experiments suggested CD3
+ PBMC plasma mem-
brane damage caused by USA300 is almost entirely Hla-
dependent (Figure 3C). To confirm these findings, CD3
+ PBMC
plasma membrane permeability was examined following 60
minutes of intoxication with USA300, USA300Dhla, USA300Dhla
comp, or USA300DsaeR/S supernatant (Figure 4A). Significantly
less CD3
+ PI
+ PBMCs were observed following treatment with
USA300Dhla or USA300DsaeR/S supernatant relative to USA300
supernatant while no difference was noted with USA300Dhla
comp supernatant, suggesting Hla is an important component of S.
aureus induced plasma membrane permeability of human T cells.
Examination of CD4
+ PBMCs and CD8
+ PBMCs (Figure 4A)
intoxicated with S. aureus supernatant indicated Hla targets both
helper T cells (CD4
+) and cytotoxic T cells (CD8
+). Using S. aureus
supernatant diluted by 1:6, 1:12, and 1:24 illustrated concentra-
tion-dependent membrane permeability of CD3
+ PBMCs that was
significantly reduced with USA300Dhla or USA300DsaeR/S
Figure 2. Hla does not significantly influence human PMN plasma membrane integrity or early bacterial survival following USA300
infection of human blood. A) Representative flow cytometry dot plots of human PMNs stained with propidium iodide following intoxication for 60
minutes with 5 hour filtered supernatant from USA300, USA300Dhla or TSB blank. B) Representative Histogram of data in part A with PMNs exposed
to supernatant from USA300 indicated by a dashed line, USA300Dhla indicated with grey shading and TSB indicated with black shading. C) Compiled
results from part A and B representing 4 separate experiments examining PMN plasma membrane integrity at 10, 30, and 60 minutes post-
intoxication with USA300 or USA300Dhla supernatant. D) Flow cytometry analysis of PMNs stained with propidium iodide at 6 hours post-infection
with USA300, USA300Dhla, or USA300DsaeR/S at the indicated MOI. Data represents 4 replicate experiments using different blood donors. E) Bacterial
counts of USA300, USA300Dhla, and USA300DsaeR/S following exposure to human blood at 0, 1, 3, and 5 hours. For E, data represents 15 replicate
experiments from more than 10 separate blood donors. *P,0.05, **P,0.01, and ***P,0.001 relative to USA300 as determined by paired one-tailed t-
test.
doi:10.1371/journal.pone.0036532.g002
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enhanced using USA300Dhla Comp supernatant (Figure 4B).
PBMCs infected with USA300, USA300Dhla, USA300Dhla comp,
or USA300DsaeR/S for 6 hours then stained with PI and either
anti-CD4 or anti-CD8 (Figure 4C) also demonstrated that Hla
significantly contributes to T cell plasma membrane permeability
during infection of PBMCs with USA300. These findings
demonstrate Hla is an important virulence gene expressed by
USA300 that induces significant T cell plasma membrane
permeability.
Hla Promotes Monocyte Plasma Membrane Permeability
The majority of CD14
+ PBMC plasma membrane permeability
caused by USA300 supernatant was very rapid and occurred in
the absence of Hla. However, as Hla-dependent plasma
membrane permeability to T cells and B cells required at least
60 minutes to become apparent and mechanisms that did not
require Hla caused substantial plasma membrane permeability to
the majority CD14
+ PBMCs within 30 minutes, we further
examined CD14
+ PBMC plasma membrane permeability follow-
ing intoxication with diluted USA300, USA300Dhla, USA300Dhla
comp, and USA300DsaeR/S supernatants (Figure 4D) as well as
during infection of PBMCs with these strains (Figure 4E). As
observed previously (Figure 3D), USA300Dhla supernatant
generated significantly more propidium iodide positive (PI
+)
CD14
+ PBMCs than USA300 supernatants at 15 minutes post-
exposure (Figure 4D). However, infection of PBMCs with
USA300, USA300Dhla, USA300Dhla comp, and USA300DsaeR/
S at an MOI of 5 and 10 demonstrated Hla significantly enhances
CD14
+ PBMC plasma membrane permeability at 6 hours post-
infection (Figure 4E). Further, cultured THP-1 cells incubated for
24 hours with USA300 supernatant containing Hla exhibited
significantly increased levels of cytotoxicity as measured by LDH
release (Figure 4F). These results indicate rapid CD14
+ PBMC
plasma membrane damage occurs following exposure to USA300
supernatant while Hla-dependent CD14
+ PBMC plasma mem-
brane permeability occurs at 6 hours post-infection with USA300
and following 24 hours intoxication of THP-1 cells with USA300
supernatant.
Hla Contributes to B Cell Plasma Membrane Permeability
Rapid CD19
+ PBMC plasma membrane permeability that did
not require Hla as well as Hla-dependent CD19
+ PBMC plasma
membrane permeability was observed following exposure to
USA300 supernatant (Figure 3E). To further examine the impact
of Hla on B cell plasma membrane permeability caused by
USA300, CD19
+ PBMCs were analyzed with PI staining following
3 hours intoxication with USA300, USA300Dhla, USA300Dhla
comp, or USA300DsaeR/S supernatant (Figure 4G). Significantly
fewer CD19
+ PI
+ PBMCs were observed following exposure to
USA300Dhla or USA300DsaeR/S supernatant relative to USA300
supernatant. In contrast, USA300Dhla Comp supernatant induced
significantly more plasma membrane permeability than USA300
supernatant. Further, CD19
+ PBMCs infected with USA300Dhla
Figure 3. Hla-dependent human T cell and B cell plasma membrane permeablity occurs following 60 minutes exposure to USA300
supernatant. A) Representative flow cytometry dot plots of human PBMCs stained with propidium iodide following intoxication with filtered 5 hour
supernatants from USA300 or USA300Dhla diluted to a final concentration of 1:6 for 30 minutes for CD14
+ PBMCs or 180 minutes for CD3
+ and CD19
+
PBMCs. B) Representative histograms of data in part A with CD3
+, CD14
+, and CD19
+ PBMCs exposed to supernatant from USA300 indicated by
a dashed line, supernatant from USA300Dhla indicated with grey shading, and TSB media alone indicated with black shading. Compiled results from
at least 4 separate experiments shown in part A using different blood donors for C) CD3
+, D) CD14
+ and E) CD19
+ PBMCs at indicated times following
intoxication with *P,0.05, **P,0.01, and ***P,0.001 relative to USA300 as determined by paired one-tailed t-test.
doi:10.1371/journal.pone.0036532.g003
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infection. A) Compiled flow cytometry analysis of PBMCs intoxicated with USA300, USA300Dhla, USA300Dhla Comp, or USA300DsaeR/S
supernatants diluted to a final concentration of 1:6 for 60 minutes then stained with propidium iodide and anti-CD3, anti-CD4, or anti-CD8. Data
represents 4 separate experiments using different blood donors. B) Compiled flow cytometry analysis of PBMCs incubated with S. aureus supernatant
diluted 1:6, 1:12, or 1:24 for 60 minutes then stained with propidium iodide and anti-CD3. Data represents 5 separate experiments using different
blood donors. C) Compiled flow cytometry analysis of CD4
+ and CD8
+ PBMCs infected for 6 hours with USA300, USA300Dhla, USA300Dhla Comp, or
USA300DsaeR/S at an MOI=10. Data represents 3 separate experiments using different blood donors. D) Compiled flow cytometry analysis of PBMCs
stained with propidium iodide and anti-CD14 following 15 minutes exposure to filtered 5 hour supernatants from USA300, USA300Dhla, USA300Dhla
Comp, or USA300DsaeR/S diluted to a final concentration of 1:6, 1:60, or 1:600. Experiments were performed at least 3 times using different blood
donors. E) Compiled flow cytometry analysis of CD14
+ PBMC cytotoxicity at 6 hours post-infection with USA300, USA300Dhla, or USA300DsaeR/S at
indicated MOI. Data represents 5 separate experiments using different blood donors. F) Cytotoxicity as determined by LDH release of THP-1 cells
intoxicated for 24 hours with USA300, USA300Dhla, USA300Dhla Comp, or USA300DsaeR/S supernatant diluted to a final concentration of 1:10. Data
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brane permeability at 20 hours when compared to PBMCs
infected with USA300 (Figure 4H). These findings demonstrate
that Hla significantly contributes to the ability of USA300 to
induce human B cell plasma membrane permeability during
infection.
Recombinant Hla Added to USA300Dhla Supernatant
Rescues Plasma Membrane Permeability Caused by
USA300 Supernatant
To further examine the susceptibility of different human blood
cell types to Hla, PMNs and CD14
+, CD3
+, or CD19
+ PBMC
plasma membrane permeability was examined following intoxica-
tion with increasing concentrations of recombinant Hla (rHla)
added to USA300Dhla supernatant or TSB media (Figure 5).
Because high concentrations of USA300 supernatant caused
robust PMN and CD14
+ PBMC plasma membrane permeability
within 10 minutes, supernatant tested against these cell types was
diluted by 1:60 or 1:600 with TSB media, respectively. Dilute
USA300 supernatant and dilute USA300Dhla supernatant induced
similar plasma membrane permeably of PMNs at 1 hour post-
intoxication. Plasma membrane permeability caused by dilute
USA300Dhla supernatant could only be significantly increased
with the addition of 5 U/mL rHla. The addition of 5 U/mL rHla
to TSB media increased PMN plasma membrane permeability by
approximately 1% (Figure 5A), further suggesting rHla has
a minimal effect on PMNs relative to other cytotoxins expressed
by USA300. Though dilute USA300 supernatant induced
significantly less CD14
+ PBMC plasma membrane permeability
than dilute USA300Dhla supernatant (Figure 5B), addition of 5 U/
mL rHla to either USA300Dhla supernatant or TSB media
significantly enhanced CD14
+ PBMC plasma membrane perme-
ability.
In accordance with prior observations, USA300 supernatant
exhibited an increased ability to generate both CD3
+ (Figure 5C)
and CD19
+ (Figure 5D) PBMC plasma membrane permeability
relative to USA300Dhla supernatant. Addition of 10 U/mL rHla to
USA300Dhla supernatant significantly enhanced CD3
+ PBMC
plasma membrane permeability, supporting prior results indicat-
ing this toxin is a primary cause of T cell cytotoxicity induced by
USA300. Notably, 10 U/mL rHla combined with USA300Dhla
supernatant generated significantly more CD3
+ PI
+ PBMCs than
10 U/mL rHla with TSB media alone suggesting Hla works
synergistically with other USA300 supernatant components to
induce CD3
+ PBMC plasma membrane permeability. Observed
CD19
+ PBMC plasma membrane permeability following in-
toxication with USA300Dhla supernatant was significantly in-
creased with the addition of 500 U rHla. Significantly enhanced
CD19
+ PBMC plasma membrane permeability was also observed
for either 0.5 or 5 U/mL rHla added to TSB media compared to
0.05 U/mL rHla with TSB media. Collectively these results
demonstrate rHla alone can induce significant CD14
+, CD3
+, and
CD19
+ PBMC plasma membrane permeability.
Hla Induces Programmed Cell Death in Monocytes, T
Cells and B Cells during Infection by USA300
A delay in observed Hla-dependent plasma membrane
permeability suggested Hla may trigger events that subsequently
lead to increased plasma membrane permeability as opposed to
directly compromising the plasma membrane integrity to allow
passage of PI. To determine if Hla-dependent plasma membrane
permeability is the result of events associated with programmed
cell death, we performed Annexin V binding and ApoBrdU
TUNEL assays on PMNs and PBMCs following infection with
USA300, USA300Dhla, USA300Dhla comp, or USA300DsaeR/S
(Figure 6). PMNs infected with USA300 exhibited significantly
increased Annexin V binding at 3 hours post-infection and
significantly enhanced ApoBrdU Tunel staining at 6 hours,
indicating phagocytosis of USA300 induces a form of programmed
PMN cell necrosis consistent with findings reported by others [36].
Though no differences could be detected in Annexin V binding to
PMNs following infection with USA300, USA300Dhla,
USA300Dhla comp, or USA300DsaeR/S (Figure 6A), significantly
decreased Annexin V binding was observed for CD3
+, CD14
+,
and CD19
+ PBMCs at 3 hours post-infection with USA300Dhla
and USA300DsaeR/S relative to USA300 (Figure 6C, 6E, and 6G).
Constitutively high levels of Annexin V binding were noted for
CD14
+ PBMCs after 3 hours incubation, though significantly
decreased Annexin V binding to CD14
+ PBMCs was observed
following intoxication with supernatant from USA300Dhla,
USA300DsaeR/S, or PBS control but not following intoxication
with USA300Dhla comp supernatant. ApoBrdU Tunel assays
further demonstrated a significant decrease of programmed cell
death for CD3
+, CD14
+, and CD19
+ PBMCs at 6 hours post-
infection with USA300Dhla and USA300DsaeR/S relative to
USA300 (Figure 6B, 6F, and 6H). In contrast, a significant
decrease in PMN ApoBrdu Tunel staining was observed for
infection with USA300DsaeR/S but not USA300Dhla. Together
these findings indicate that Hla activity during infection of human
blood by USA300 elicits properties characteristic of programmed
cell death in human T cells, B cells, and monocytes but not PMNs.
Intoxication with Recombinant Hla Induced Programmed
Cell Death of T Cells, B Cells, and Monocytes
To verify Hla induces programmed cell death of T cells, B cells,
and monocytes, Annexin V binding and ApoBrdU Tunel assays
were used to examine PMNs and PBMCs intoxicated for 60
minutes with increasing concentrations of rHla (Figure 7). A
significant increase of Annexin V binding was observed for CD3
+,
CD14
+, and CD19
+ PBMCs following intoxication with 5 U/mL
rHla for 60 minutes while no significant difference was noted for
Annexin V binding PMNs (Figure 7A). ApoBrdU Tunel assays
confirmed a concentration dependent increase in CD3
+, CD14
+,
and CD19
+ PBMC programmed cell death in response to
intoxication with rHla not observed for PMNs (Figure 7B).
Together these results demonstrate rHla alone induces pro-
grammed cell death in CD3
+, CD14
+, and CD19
+ PBMCs in
a concentration dependent manner while having a minimal
influence on PMNs.
represents 3 separate experiments. G) Compiled flow cytometry analysis of PBMCs intoxicated for 3 hours at 37uC with USA300, USA300Dhla,
USA300Dhla Comp, or USA300DsaeR/S supernatants diluted to a final concentration of 1:6 then stained with propidium iodide and anti-CD19. Data
represents 4 separate experiments using different blood donors. H) Compiled flow cytometry analysis of CD19
+ PBMCs stained with propidium iodide
at 20 hours post-infection with USA300, USA300Dhla, USA300Dhla Comp, or USA300DsaeR/S at an MOI=10. Data represents 5 separate experiments
using different blood donors. *P,0.05, **P,0.01, and ***P,0.001 relative to USA300 as determined by paired one-tailed t-test.
doi:10.1371/journal.pone.0036532.g004
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Hla is a prominent S. aureus virulence factor highly expressed by
USA300 and thought to significantly contribute to the virulence of
infections caused by this strain [8,11,19], yet how this toxin acts to
promote pathogenesis is not entirely clear. This investigation
demonstrates Hla is the principle component produced by
USA300 generating T cell plasma membrane permeability and
also significantly compromises B cell and monocyte plasma
membrane integrity. In contrast, Hla has a minimal impact on
PMN plasma membrane permeability and early bacterial survival
during USA300 infection of human blood.
Factors other than Hla in USA300 supernatant contributed to
substantial PMN and CD14
+ PBMC plasma membrane perme-
ability within 15 minutes post-intoxication and caused the majority
of observed plasma membrane permeability to these cell types.
The observed rapid plasma membrane permeability of PMNs and
monocytes in response to USA300 supernatant is likely due to the
activity of other pore-forming toxins such as phenol-soluble
modulin peptides [27], Panton-Valentine leukocidin [28,29],
leukocidin A/B or G/H [25,30], and c-hemolysin [31]. However,
while Hla-dependent PMN plasma membrane permeability was
not detected during USA300 infection and only minimally
detected following intoxication with rHla, Hla significantly
influenced CD14
+ PBMC plasma membrane integrity at 6 hours
post-infection with USA300 and rHla alone increased CD14
+
PBMC plasma membrane permeability in a concentration de-
pendent manner following 60 minutes intoxication. Moreover,
USA300 supernatant generated THP-1 cell cytotoxicity that was
significantly enhanced by the presence of Hla following 24 hours
intoxication. Together these findings indicate Hla produced by
USA300 has a significant impact on monocyte plasma membrane
permeability during infection but only minimally influences PMN
plasma membrane integrity.
Human PBMCs exposed to USA300 supernatant exhibited
Hla-dependent T cell and B cell plasma membrane permeability
that was only detectable following 60 minutes intoxication.
Analysis of PBMCs infected with USA300 relative to USA300Dhla
and intoxication of PBMCs with rHla further demonstrated Hla
significantly impacts T cell and B cell plasma membrane
permeability. Importantly, absence of Hla almost entirely
abolished the capacity of USA300 to cause T cell plasma
membrane permeability. In contrast, B cells intoxicated with
Figure 5. Recombinant Hla alone induces human monocyte, T cell, B cell plasma membrane permeability. Compiled flow cytometry
analysis of A) human PMNs intoxicated with indicated amounts of recombinant Hla (rHla) and TSB or S. aureus supernatant diluted 1:60 for 60
minutes, B) human CD14
+ PBMCs intoxicated with indicated amounts of rHla and TSB or S. aureus supernatant diluted 1:600 for 60 minutes, C) human
CD3
+ PBMCs intoxicated with indicated amounts of rHla and S. aureus supernatant diluted 1:6 for 60 minutes or D) human CD19
+ PBMCs intoxicated
with indicated amounts of rHla and S. aureus supernatant diluted 1:6 for 3 hours. Quantity of rHla added is given in hemolytic units per mL (U/mL).
Figures represent at least 4 separate experiments using different blood donors with *P,0.05, **P,0.01, and ***P,0.001 relative to USA300Dhla as
determined by paired one-tailed t-test.
doi:10.1371/journal.pone.0036532.g005
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PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e36532Figure 6. Hla induces programmed cell death in human monocytes, T cells and B cells during USA300 infection. Compiled flow
cytometry analysis of human PMNs or PBMCs infected at a MOI of 10 with USA300, USA300Dhla, USA300Dhla Comp, USA300DsaeR/S, or a DPBS
control then examined using an Annexin V binding assay at 3 hours (A, C, E, and G) or ApoBrdU Tunel assay at 6 hours (B, D, F, and H). Figures
represent 4 separate experiments using different blood donors with *P,0.05, **P,0.01, and ***P,0.001 relative to USA300 as determined by paired
one-tailed t-test for A, C, E and G or one-way repeated measures ANOVA with Tukey’s post-test for B, D, F, and H.
doi:10.1371/journal.pone.0036532.g006
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PLoS ONE | www.plosone.org 9 May 2012 | Volume 7 | Issue 5 | e36532USA300 supernatant exhibited rapid plasma membrane perme-
ability in the absence of Hla as well as plasma membrane
permeability following 60 minutes of intoxication that required
Hla. These findings indicate Hla is the principle component
produced by USA300 generating T cell plasma membrane
permeability while B cells are susceptible to Hla in addition to
other pore-forming toxins generated by USA300.
How Hla influences the pathogenesis of S. aureus disease is not
completely understood. S. aureus isolates that cause toxic shock
syndrome have long been noted for their lack of alpha-toxin
production [37,38,39,40], yet experimental evidence clearly
demonstrates Hla is critical for USA300 pathogenesis during soft
tissue infections and pneumonia caused by S. aureus [5,19,41,42].
Diminished expression of Hla by S. aureus strains that cause toxic
shock syndrome may be at least partially explained by the results
in this study showing Hla is the primary factor responsible for T
cell plasma membrane permeability caused by S. aureus. In the
context of toxic shock syndrome, a disease generated by
nonspecific binding of TSS Toxin-1 (TSST-1) to the major
histocompatibility complex class II molecule of T cells, Hla activity
would lead to compromised T cell function that would inhibit the
non-specific polyclonal T-cell activation and expansion induced by
TSST-1. Thus reduced Hla production by S. aureus would be
expected in a disease such as toxic shock syndrome that requires T
cells to manifest.
As opposed to the rapid plasma membrane permeability that
did not require Hla observed for PMNs, monocytes and B cells,
Hla-dependent T cell and B cell plasma membrane permeability
to PI became apparent only after 60 minutes of intoxication. This
observation implies Hla does not immediately induce plasma
membrane permeability to PI but instead triggers events that
subsequently compromise plasma membrane integrity. Studies
using Annexin V binding and ApoBrdU Tunel assays indicated
Hla-dependent plasma membrane permeability was associated
with induction of features characteristic of programmed cell death
in monocytes, T cells, and B cells but not PMNs during infection
by USA300. Further analysis of PBMCs and PMNs demonstrated
a concentration dependent increase in T cells, B cells, and
monocytes undergoing programmed cell death following in-
toxication with rHla alone that was not observed for PMNs.
These results are supported by findings made by others suggesting
Hla induces apoptosis in T cells and endothelial cells [34,43].
This investigation demonstrates that Hla is the principle
component produced by USA300 responsible for human T cell
plasma membrane permeability and a significant cause of human
monocyte and human B cell plasma membrane permeability.
Whereas other USA300 cytotoxic factors immediately generate
plasma membrane permeability to PI, Hla is shown to induce
programmed cell death in susceptible cell types that subsequently
compromises plasma membrane integrity. Together these findings
demonstrate that Hla has a significant impact on human immune
cell integrity and function during USA300 infection and may
partially explain why both passive immunization with Hla-specific
anti-serum as well as active immunization with non-toxigenic
recombinant Hla has proven effective in murine models of soft
tissue infection and pneumonia [5,20] given the numerous
unsuccessful past attempts at developing a suitable vaccine to
protect against S. aureus infection [44,45,46].
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